GlassScriptPhysician profile
Tushar Shah
NPI 1174785158
$1,314.21
in general payments reported to CMS, 2019-2025
17 companies · $354 in 2025
The $354 reported for 2025 was more than what 86% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $39.34 · 2021: $61.90 · 2022: $190 · 2023: $366 · 2024: $302 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,022.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $292.10 | 2022-2024 | Xarelto |
| Abbvie INC. | $226.53 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $112.19 | 2021-2025 | Xifaxan |
| Gilead Sciences, INC. | $105.52 | 2023 | Veklury |
| Mallinckrodt Hospital Products INC. | $84.19 | 2024-2025 | Terlivaz |
| Ucb, INC. | $82.38 | 2023-2025 | Briviact |
| Inari Medical, INC. | $81.21 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $77.66 | 2020-2025 | |
| Xeris Pharmaceuticals, INC. | $67.74 | 2023-2025 | Gvoke Hypopen |
| Novo Nordisk INC | $62.05 | 2022-2024 | Ozempic, Rybelsus |
| Genzyme Corporation | $26.64 | 2024 | |
| Merck Sharp & Dohme LLC | $20.53 | 2024 | Dificid |
| Stryker Corporation | $18.71 | 2025 | Ivas |
| Pfizer INC. | $16.13 | 2023 | |
| Eisai INC. | $14.41 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.39 | 2023 | Lifevest |
| Cmp Pharma, INC. | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tushar Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.